OR WAIT null SECS
June 09, 2022
Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.
June 08, 2022
FDA has approved GSK’s vaccine for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.
June 07, 2022
Sanofi will grant Regeneron worldwide exclusive license rights to Libtayo, a treatment for non-small cell lung cancer.
June 03, 2022
Cambrex’s acquisition of Q1 Scientific expands the company’s storage services in the European market.
June 02, 2022
The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.
Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
May 24, 2022
AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.
EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union.
Investment has been made into a new science hub at the University of Edinburgh for the development of treatments for lung infections and future pandemics.